Congratulations to Eva Elmerstig and her research team on the SEK 2 million grant from the Mats Paulsson Foundation to advance their work on eHealth support for involuntary childlessness.

ReproUnion celebrated the milestone with all contributing fertility and reproductive clinics who play a crucial role in collecting and processing the biological material and data that makes RUBIC possible.

By blending expert lectures with practical exercises, the course equipped the participants with insights and tools, which they can put directly into practice, if they wish to pursue the journey from science to commercialisation.

The third ReproTalk event on 8 September tuned in on how researchers and clinicians at Rigshospitalet are helping to set the global standard for fertility preservation ahead of treatments that may harm the reproductive potential for both girls and women.

It builds on research published in Human Reproduction showing that paracetamol may impair the development of the fertilized egg in the very first days after conception.

There is so much to be said about the ovaries in relation to fertility and many young women showed genuine interest in learning about their own biology, while having thoughtful discussions with Stine Gry Kristensen and Sandra Søgaard Tøttenborg.

Between April and June, nine ReproUnion-affiliated young researchers and doctors participated the 12-week online e-Campus Innovation Course, a programme developed in collaboration with SmiLe Venture...

The European Mental Health Week was a timely opportunity to shed light on the emotional strain that fertility treatments place on individuals and couples. By addressing both medical and emotional needs, a ReproUnion Innovation project aspires to support fertility treatment to make it more effective, less isolating, and more humane.

As one of the first commercial partners to access the ReproUnion Biobank & Infertility Cohort (RUBIC), Caerus Biotech is collaborating with Rigshospitalet to analyze samples from 1000 men, using the company’s MiOXSYS system designed to measure oxidative stress in semen.

At the event organized by ReproYoung the topic was male and female infertility – assessment and prognostic factors with talks by Anja Pinborg and Niels Jørgensen from Rigshospitalet.